Quantcast
Last updated on April 19, 2014 at 1:20 EDT

Latest Unitaid Stories

2014-04-01 16:25:22

GENEVA, April 1, 2014 /PRNewswire/ -- Access to dolutegravir could improve millions of lives in developing countries The Medicines Patent Pool (MPP) and ViiV Healthcare announced a new collaboration on HIV medicines today, signing two licensing agreements to increase access to dolutegravir (DTG), a promising new antiretroviral, for both adult and paediatric care. The agreements would allow generic...

2013-03-04 08:30:16

Former Johnson & Johnson Chairman of Pharmaceuticals brings global product development and commercialization expertise NEW YORK, March 4, 2013 /PRNewswire-USNewswire/ -- TB Alliance, a not-for-profit organization with the mission of developing better, faster-acting, and affordable TB treatments, announces the election to its Board of Directors of David Norton, former Company Group Chairman of Global Pharmaceuticals for Johnson & Johnson (J&J). Mr. Norton brings to TB Alliance...

2013-02-25 12:24:56

Global health expert and diplomat to lend skills, support to optimize new TB drug introductions WASHINGTON and NEW YORK, Feb. 25, 2013 /PRNewswire-USNewswire/ -- TB Alliance, a not-for-profit organization with the mission of developing new, improved, and affordable TB treatments, announces the election of Karl Hofmann, President and CEO of Population Services International (PSI), as President of the TB Alliance's Stakeholders Association (SHA), thereby assuming a seat on its Board of...

2012-08-06 10:24:42

SUNNYVALE, Calif., Aug. 6, 2012 /PRNewswire/ -- Cepheid (Nasdaq: CPHD) today announced the first in a series of agreements with the Bill & Melinda Gates Foundation, the United States President's Emergency Plan for AIDS Relief (PEPFAR), the United States Agency for International Development (USAID) and UNITAID to buy-down the price of the Xpert(®) MTB/RIF test in an effort to drive adoption of the technology as a critical tool in interrupting the transmission cycle of tuberculosis....

2012-06-14 06:24:32

SUNNYVALE, Calif., June 14, 2012 /PRNewswire/ -- Cepheid (Nasdaq: CPHD) today welcomed UNITAID's announcement that it has approved funding of $30 million to scale up access to the "ground-breaking" Xpert MTB/RIF in high burden developing countries (HBDC). According to UNITAID, the funds will be used to roll out Xpert-based programs in around 20 countries, in addition to supporting a buy-down of the price of each Xpert MTB/RIF cartridge from $17 currently to around $10. "We are...

2012-03-13 14:42:00

GENEVA, March 13, 2012 /PRNewswire/ -- The Global Fund to Fight AIDS, Tuberculosis and Malaria today welcomed a $340 million contribution by Japan, the highest amount that Japan has ever made in 10 years of vigorous support for the Global Fund. Japan is now making its first payment of US$ 216 million for its 2012 contribution. "Japan has always been a leader in the fight against disease, but this is a great vote of confidence in our commitment to saving lives," said Gabriel Jaramillo,...

2011-10-03 08:51:00

SAO PAULO, Oct. 3, 2011 /PRNewswire/ -- This week's edition of IstoE Dinheiro, Brazil's most widely read weekly economic magazine, features a 5-page article on the 15 new Joint-Ventures formed by Brasilinvest. Brazil's foremost merchant bank, led by Mario Garnero, disclosed the new partnerships to the public during the III Sustainable Development Forum, which took place last September 26 at the Harvard Club (Harvard Hall) in New York. The article names the cross-sector JVs "Garnero's...

2011-09-26 08:09:00

NEW YORK, Sept. 26, 2011 /PRNewswire/ -- Mario Garnero, Chairman of Brasilinvest, Brazil's pioneer merchant bank, is to head the III Sustainable Development Forum, which will take place on September 26 at the Harvard Club (Harvard Hall) in New York. Entitled "Brazil: The New Global Green Economy", the Conference concentrates on the importance of sustainable development for Brazil and the world. The Forum is organized by Forum das Americas and UNA-Brazil, two not-for-profits chaired by...

2011-08-31 11:00:00

NEW YORK, Aug. 31, 2011 /PRNewswire/ -- The Prix Galien USA Committee, responsible for awarding the most prestigious prize in biopharmaceutical research and development, announced today that Dr. Paul Farmer will be awarded the 2011 Pro Bono Humanum Award during the 5th Annual Prix Galien USA Award Ceremony. The annual award presentation accompanies a series of other awards honoring companies who have made innovative contributions to biopharmaceutical and medical technology research and...

2010-09-09 08:00:00

NEW YORK, Sept. 9 /PRNewswire/ -- The Prix Galien USA committee, responsible for awarding the most prestigious prize in biopharmaceutical research and development, today announced the 2010 winner of the Pro Bono Humanum Award for the 4th annual Prix Galien USA Awards competition. The award, recognizing exemplary and innovative efforts to improve the human condition, will be presented to UNITAID in partnership with the Clinton Health Access Initiative (CHAI) for their tremendous work...